Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion

Stroke

Volumn 47, Issue 4, 2016, Pages 999-1004

  Ribo, Marc ^a   Molina, Carlos A ^a   Cobo, Erik ^b   Cerdà, Neus ^c   Tomasello, Alejandro ^d   Quesada, Helena ^e   De Miquel, Maria Angeles ^f   Millan, Mónica ^a   Castaño, Carlos ^a   Urra, Xabier ^g   Sanroman, Luis ^g   Dàvalos, Antoni ^g   Jovin, Tudor ^h  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^c BioClever   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e Stroke Unit   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Odds ratio; Probability; Reperfusion; Stroke; Thrombectomy

Indexed keywords

AGED; ALBERTA STROKE PROGRAM EARLY COMPUTED TOMOGRAPHIC SCORE; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; REPERFUSION; TIME TO TREATMENT; WORKFLOW; BRAIN ISCHEMIA; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; STROKE; THROMBECTOMY; TIME FACTOR; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE; THROMBECTOMY; TIME FACTORS; TREATMENT OUTCOME; WORKFLOW;

EID: 84960157707     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.011721     Document Type: Article

References (13)

1. Zaidi SF, Aghaebrahim A, Urra X, Jumaa MA, Jankowitz B, Hammer M, et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy. Stroke. 2012;43:3238-3244. doi: 10.1161/STROKEAHA.112.671594.
2. Yoo AJ, Chaudhry ZA, Nogueira RG, Lev MH, Schaefer PW, Schwamm LH, et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke. 2012;43:1323-1330. doi: 10.1161/STROKEAHA.111.639401.
3. Mazighi M, Chaudhry SA, Ribo M, Khatri P, Skoloudik D, Mokin M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation. 2013;127:1980-1985. doi: 10.1161/CIRCULATIONAHA.112.000311.
4. Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, et al.; IMS III Trialists. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014;13:567-574. doi: 10.1016/S1474-4422(14)70066-3.
5. Asif KS, Lazzaro MA, Zaidat O. Identifying delays to mechanical throm-bectomy for acute stroke: onset to door and door to clot times. J Neurointerv Surg. 2014;6:505-510. doi: 10.1136/neurintsurg-2013-010792.
6. Sun CH, Nogueira RG, Glenn BA, Connelly K, Zimmermann S, Anda K, et al. "Picture to puncture": a novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke. Circulation. 2013;127:1139-1148. doi: 10.1161/CIRCULATIONAHA.112.000506.
7. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al.; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296-2306. doi: 10.1056/NEJMoa1503780.
8. Molina CA, Chamorro A, Rovira À, de Miquel A, Serena J, Roman LS, et al. REVASCAT: a randomized trial of revascularization with SOLITAIRE FR device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset. Int J Stroke. 2015;10:619-626. doi: 10.1111/ijs.12157.
9. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674.
10. Sun CH, Connelly K, Nogueira RG, Glenn BA, Zimmermann S, Anda K, et al. ASPECTS decay during inter-facility transfer predicts patient outcomes in endovascular reperfusion for ischemic stroke: a unique assessment of dynamic physiologic change over time. J Neurointerv Surg. 2015;7:22-26. doi: 10.1136/neurintsurg-2013-011048.
11. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al.; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009-1018. doi: 10.1056/NEJMoa1414792.
12. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al.; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019-1030. doi: 10.1056/NEJMoa1414905.
13. Aghaebrahim A, Leiva-Salinas C, Jadhav AP, Jankowitz B, Zaidi S, Jumaa M, et al. Outcomes after endovascular treatment for anterior circulation stroke presenting as wake-up strokes are not different than those with witnessed onset beyond 8 hours. J Neurointerv Surg. 2015;7:875-880. doi: 10.1136/neurintsurg-2014-011316.